Because anti-PD1 is an immunomodulator, we first performed a PPI analysis focusing on the changes in immune system-related proteins caused by the combined effect of anti-PD1 and high-dose AA in tumor tissues from a syngeneic lung cancer mouse model. The gene discussed is PDCD1; the disease is lung carcinoma.